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Abstract
The mechanism of sodium retention and its location in kidney tubules may vary with 
time in nephrotic syndrome (NS). We studied the mechanisms of sodium retention 
in transgenic POD-ATTAC mice, which display an inducible podocyte-specific ap-
optosis. At day 2 after the induction of NS, the increased abundance of NHE3 and 
phosphorylated NCC in nephrotic mice compared with controls suggest that early 
sodium retention occurs mainly in the proximal and distal tubules. At day 3, the 
abundance of NHE3 normalized, phosphorylated NCC levels decreased, and cleav-
age and apical localization of γ-ENaC increased in nephrotic mice. These findings 
indicate that sodium retention shifted from the proximal and distal tubules to the 
collecting system. Increased cleavage and apical localization of γ-ENaC persisted at 
day 5 in nephrotic mice when hypovolemia resolved and steady-state was reached. 
Sodium retention and γ-ENaC cleavage were independent of the increased plasma 
levels of aldosterone. Nephrotic mice displayed decreased glomerular filtration rate 
and urinary potassium excretion associated with hyperkaliemia at day 3. Feeding ne-
phrotic mice with a low potassium diet prevented hyperkaliemia, γ-ENaC cleavage, 
and led to persistent increased phosphorylation of NCC. These results suggest that 
potassium homeostasis is a major determinant of the tubular site of sodium retention 
in nephrotic mice.
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1 |  INTRODUCTION
The mechanisms of edema formation in nephrotic syn-
drome (NS) have long been a subject of investigation.1 
The “underfilling” hypothesis postulates that proteinuria 
and subsequent hypoalbuminemia lead to decreased in-
travascular oncotic pressure, altering Starling forces and 
inducing a transfer of water and solutes from plasma into 
the interstitial space, leading to hypovolemia. The ensuing 
activation of the Renin-Angiotensin-Aldosterone System 
(RAAS) results in secondary renal retention of sodium 
(and therefore water) by activation of ENaC in the con-
necting tubules and collecting ducts.2 The “overfilling” 
hypothesis states that proteinuria itself can cause primary 
sodium retention via the direct processing and activation 
of γ-ENaC by urinary serine proteases.3 Thus, the aldo-
sterone-sensitive distal nephron (ASDN) is thought to be 
the principal site of sodium retention. Indeed, increased 
Na,K-ATPase expression and activity have been consis-
tently reported in the cortical collecting duct (CCD) of 
proteinuric rats.4 ENaC seems to be a key player in sodium 
retention in NS, and aldosterone seems to play a permis-
sive role in ENaC activation. The expression and apical 
targeting of ENaC have been observed to increase in an 
aldosterone-dependent manner in the CCD of proteinuric 
rats.5,6 Moreover, increased apical ENaC targeting has not 
been observed in adrenalectomized puromycin aminonu-
cleoside (PAN) nephrotic rats with clamped plasma aldo-
sterone, even when they still displayed amiloride-sensitive 
sodium retention.6,7
The underfilling and overfilling hypotheses are not mu-
tually exclusive since the one or the other mechanism may 
dominate depending on the development stage of NS, the 
rate of hypoproteinemia and the absolute plasma oncotic 
pressure. Current experimental models of NS have severe 
limitations. Most studies have been conducted in rats in-
jected with toxic substances such as PAN, which induces 
massive proteinuria and sodium retention but also damages 
kidney tubules.6 In addition, knock-out mouse models for 
podocyte-specific proteins such as nephrin8 or podocin,9 
which are required for the integrity of the glomerular filtra-
tion barrier, display massive perinatal lethality and/or se-
vere renal failure that precludes their utilization as models 
of idiopathic NS.
In order to circumvent these problems, we used the 
POD-ATTAC transgenic mouse model, in which NS stems 
from an inducible podocyte-specific apoptosis,10 to test 
our hypothesis that different mechanisms drive sodium re-
tention depending on hemodynamics and the development 
phase of NS.
2 |  METHODS
2.1 | Animal experiments
All animal experiments were approved by the Institutional 
Ethical Committee of Animal Care of the University of 
Geneva and Cantonal authorities.
POD-ATTAC transgenic mice kindly provided by Dr. 
Scherer (Southwestern Texas University, Dallas, TX) were bred 
and housed in the animal facility of the Faculty of Medicine 
of Geneva. Genotyping of transgenic mice was performed by 
PCR analysis of ear biopsies using the following primers: for-
ward, 5′- GAA AGT GCC CAA ACT TCA GAG CAT TAG 
G - 3′ and reverse, 5′ - AAC TGA GAT GTC AGC TCA TAG 
ATG GGG G - 3′. NS was induced by intraperitoneal injection 
of 0.5 μg/g body weight of the chemical dimerizer, AP20187 
(Takara Bio Inc. Kusatsu, Japan), in 8-10 weeks old male trans-
genic mice. Male wild-type littermates were used as controls 
and were injected with the same dose of chemical dimerizer.
Mice were individually housed in metabolic cages 
(Tecniplast, Buguggiate, Italy). Water and food (Provimi-
Kliba, Kaiseraugst, Switzerland) containing normal (1.55% 
wt/wt) or low (0.01% wt/wt) potassium were provided ad li-
bitum. After 1 d of adaptation, food and water intake, body 
weight, and 24 hours urine volume were recorded daily. 
Urine was collected each day till day 5 after dimerizer in-
jection for chemical analysis. On the 2nd, 3rd, or 5th day after 
dimerizer injection, mice were anesthetized by 100 mg/kg 
ketamine and 5 mg/kg xylazine (Bayer Healthcare, Berlin, 
Germany). Blood was collected via the submandibular vein 
for chemical analysis, ascites was weighed on an absorptive 
tissue after the opening of the peritoneal cavity, and kidneys 
were removed before sacrifice by lethal bleeding. Kidneys 
were either fixed by immersion in 4% paraformaldehyde for 
histological analysis or frozen in liquid nitrogen and stored at 
-80% for subsequent RNA and protein extraction.
2.2 | Biological parameters
Blood parameters (sodium, potassium, chloride, bicarbonate, 
creatinine, hematocrit) were measured on day 2, 3, or 5 using 
the Epoc technology (Siemens Healthcare, Erlangen, Germany). 
Urinary sodium, potassium, chloride, and creatinine concentra-
tions were measured using a UniCel DxC800 Synchron Clinical 
System automated analyzer (Beckman Coulter, Brea, CA). 
Plasma and urinary proteins were measured with a Konelab 
automated analyzer (Thermo-Fisher, Waltham, MA). Results 
are expressed in mmol/l except protein concentrations, which 
are expressed in g/L. The urinary protein/creatinine ratio was 
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calculated for normalized with respect to the volume of urine 
excretion. Plasma aldosterone levels were measured accord-
ing to standard procedures using a radioimmunoassay (Coat-
A-Count RIA kit; Siemens Medical Solutions Diagnostics, 
Ballerup, Denmark). Results are means ± SEM.
2.3 | Glomerular filtration rate
Mice were anesthetized with isoflurane and a miniatur-
ized imager device (Mannheim Pharma and Diagnostics, 
Mannheim, Germany) was mounted onto the animal’s back. 
The skin background signal was recorded for 5 minutes 
before intravenous injection of 150  mg/kg FITC-sinistrin 
(Mannheim Pharma and Diagnostics, Germany). Then, trans-
cutaneous fluorescence was recorded for 1h in conscious 
animals. mGFR (µL/min) was calculated from the decrease in 
fluorescence intensity over time (ie, plasma half-life of FITC-
sinistrin) using a two-compartment model, the mouse body 
weight and an empirical conversion factor using the MPD Lab 
software (Mannheim Pharma and Diagnostics, Germany), as 
previously described.11 Results are means ± SEM.
2.4 | Functional diuretic tests
For diuretic response studies, we performed an intraperitoneal 
injection of hydrochlorothiazide (50 mg/kg) to inhibit NCC or 
benzamil (5 mg/kg) to inhibit ENaC, as previously described.12 
Urinary Na+ excretion was measured 24 hours before and 24 
hours after diuretic administration. Results are expressed as a 
ratio of urinary sodium/urinary creatinine concentrations after 
or before diuretic administration and as means ± SEM.
2.5 | MR antagonist
Potassium canrenoate (Sigma-Aldrich, Saint Louis, MI, 
USA) was used as a mineralocorticoid receptor (MR) antago-
nist. POD ATTAC and FVB (Friend leukemia virus B) mice 
were treated with daily subcutaneous injection of canrenoate 
(50 mg/kg) starting the day before the injection of the dimer-
izer, until sacrifice on the 3rd day after dimerizer injection.
2.6 | RNA extraction and real-time qPCR
Total RNA was extracted from kidney and hypothalamus 
tissues using the NucleoSpin RNA II kit (Macherey-Nagel, 
Düren, Germany) according to the manufacturer instruc-
tions. Five hundred nanograms of RNA were used to synthe-
size cDNA using the qScript cDNA Supermix (Quantabio, 
Gaithersburg, MD). Real-time PCR was performed on 10 ng 
of cDNA using 0.5 mM of each primer, 6 µL of SYBR Green 
Master Mix (Applied Biosystems) and 2 µL of water to obtain a 
final reaction volume of 12 µL. The primers used are described 
in Table 1. Mouse acidic ribosomal phosphoprotein, P0, was 
used as the internal standard except where otherwise noted. 
Duplicate amplification reactions were performed with an ABI 
prism 7000 Sequence Detection System (Applied Biosystems). 
Fold difference in cDNA abundance (F) was calculated using 
the formula F = 2(Ct1−Ct2), where Ct1 and Ct2 are the number 
of cycles required to reach the threshold of amplicon abun-
dance for experimental and control conditions, respectively. 
Normalization to one control animal was performed to assess 
biological variability in both controls and nephrotic groups. 
Results were expressed as fold of control ± SEM.
2.7 | Western blotting
Kidney tissues were lysed as previously described.13 Proteins 
were quantified using a BCA protein assay kit (Pierce, 
Rockford, Il), and subjected to SDS-PAGE and blotted 
onto polyvinylidene difluoride membranes (Immobilon-P; 
Millipore, Bedford, MA) using standard methods. The an-
tibodies used are indicated in Table 2. Protein signals were 
quantified with image J software. Results are expressed as 
the ratio of the densitometry of the band of interest to the 
loading control or to the Coomassie blue staining. Then 
T A B L E  1  Primers for qRT-PCR
Name Forward Reverse
NHE3 CAG GTG GTC ACC TTC AAA TG GGG ACA GGT GAA AGA CGA TT
NKCC2 TGG GTT GTC AAC TTC TGC AA GCT CCG GGA AAT CAG GTA GT
NCC ACC ACC ATC TCC TAC CTT GC GGA GTC ATG GTG TCG TTC AC
α-ENaC CAG ACT TGG AGC TTT GAC AAG GA ACT TCT CTG TGC CTT GTT TAT ATG TGT T
β-ENaC CAG ACT GGG CCT ATT GCT ATC TAA A ACA TGC TGA GGC AGG TCT CTC T
γ-ENaC CCG AGA TCG AGA CAG CAA TGT CGC TCA GCT TGA AGG ATT CTG
AQP2 CAT GAG ATT ACC CCT GTA GAA ATC C CGG CTG TTG CAT TGT TGT G
Vasopressin TCG CCA GGA TGC TCA ACA CT GGA AGT AGC AGG CGG AGG AG
SGK1 CCA AAC CCT CCG ACT TTC AC CCT TGT GCC TAG CCA GAA GAA
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normalization to one control animal was also performed to 
assess biological variability in both controls and nephrotic 
groups. Results were expressed as fold of control ± SEM.
Coomassie blue staining was performed on urine sam-
ples in order to detect the proteinuria of POD-ATTAC mice. 
Each day following dimerizer injection, urine samples from 
FVB and POD-ATTAC mice were taken, pooled, and diluted 
(1:20) for comparison to a standard consisting of serial dilu-
tions of bovine serum albumin (BSA). Urine pools and BSA 
solutions were then denatured by heating for 5 minutes at 
95°C and loaded into polyacrylamide gel for SDS-PAGE.
2.8 | Immunofluorescence
Paraformaldehyde-fixed kidneys were dehydrated and paraf-
fin-embedded. Kidney sections of 5 µm thickness were used 
for analysis. Non-specific binding was blocked with normal 
goat serum 2% for 20 minutes. The sections were incubated 
with primary antibody (Table 2) (diluted in PBS with 2% 
BSA) overnight at 4°C and then incubated 1 h with a sec-
ondary fluorescent antibody (goat anti-rabbit IgG AlexaFluor 
488) at room temperature. Samples were mounted on micro-
scope slides using Vectashield mounting medium (Maravai 
Life Science, San Diego, CA, USA) with DAPI for nuclear 
counterstaining. Fluorescence images were acquired using a 
LSM 710 confocal laser-scanning microscope (Carl Zeiss, 
Oberkochen, Germany). Z-stack images were summarized 
using ImageJ software (National institute of Health, US).
2.9 | Mathematical modeling of Na+ 
transport along the nephron
Model predictions of transepithelial sodium fluxes and ox-
ygen consumption rates were obtained using a published 
model of transport along the superficial nephron of a rat.12,14 
Tubular sodium transport and oxygen consumption rates are 
expressed in mmol/h/100 g body weight to allow for a direct 
comparison between rat and mouse data.
2.10 | Statistics
Results are given as the mean ± SEM from n independent 
experiments. Prism version 7.02 (GraphPad Software, San 
Diego,California,USA) was used for statistical analysis. The 
normal distribution of the population from which sample 
data was extracted was determined by a Shapiro-Wilk test. 
For parametric data, statistical differences were assessed 
using a two-tailed unpaired t test for comparison between 
two groups or one-way ANOVA with multipair wise com-
parison from Tukey for comparisons between more than two 
groups. For non-parametric data, statistical differences were 
assessed using the Mann-Whitney test for comparison be-
tween two groups or by the Kruskal-Wallis test with a mul-
tipair wise comparison from Dunn for comparisons between 
more than two groups. A P- value <.05 was considered 
significant.
3 |  RESULTS
3.1 | POD-ATTAC mice rapidly developed 
nephrotic syndrome
After dimerizer injection, POD-ATTAC mice rapidly de-
veloped nephrotic proteinuria mainly composed of albu-
min as detected by Coomassie blue staining (Figure 1A). 
Proteinuria started at day 2 after dimerizer injection, became 
massive at day 3 and remained stable until at least the 5th 
day (Figure 1B). In parallel, plasma protein concentration 
Name Specie Dilution Supplier Reference
NHE3 Rabbit 1/1000 StressMarq 41
NKCC2 Rabbit 1/1000 J Loffing 42
NCC Rabbit 1/1000 J Loffing 43
NCC-pT53 Rabbit 1/1000 J Loffing 43
NCC-pT58 Rabbit 1/1000 J Loffing 43
α-ENaC Rabbit 1/1000 J Loffing 42
β-ENaC Rabbit 1/1000 StressMarq Biosciences Ref SPC-404
γ-ENaC Rabbit 1/1000 StressMarq Biosciences Ref SPC405
AQP2 Rabbit 1/1000 RW Schrier 37
E-Cadherin Mouse 1/2000 BD Biosciences Ref 610404
β-actin Mouse 1/10000 Sigma A5441
SPAK Rabbit 1/100 Millipore 07-2271
SPAK-pSer373 Rabbit 1/500 Millipore 07-2273
T A B L E  2  Antibodies used for 
Western blots
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was decreased from days 2 to day 5 (Figure 1C). Proteinuria 
was associated with the development of ascites, decreased 
natriuresis and weight gain (Figure 1D,E, Supplementary 
Figure 1C) starting at day 2 and indicated large sodium and 
fluid retention.
Both hematocrit and blood hemoglobin concentration 
were increased at day 2 and 3 in proteinuric mice as com-
pared to control mice (Table 3), indicating the contrac-
tion of circulating volume at the onset of NS. Ascites was 
associated with decreased natremia starting at day 2 and 
becoming significant at day 3. This finding suggests that 
expansion of extracellular volume was due to both primary 
sodium and water retention during this early phase (Figure 
1 and Table 3). On the 5th day after dimerizer injection, 
proteinuria, and hypoproteinemia persisted but hemato-
crit, hemoglobin, and natremia were normalized when 
compared to control mice after massive sodium retention 
and ascites (Figure 1 and Table 3). Finally, POD-ATTAC 
mice displayed an early and progressive decrease in GFR 
after the induction of proteinuria, becoming apparent at 
day 2, maximal at day 3 and remaining stable until day 5 
(Figure 1F). This decreased GFR was associated with de-
creased urinary potassium excretion (Figure 9A) and hy-
perkalemia (Table 3) starting at day 3 and sustained until 
day 5.
3.2 | Increased expression levels of NHE3  
and phosphorylation of NCC are present at the 
onset of NS
Experiments performed at day 2 after the injection of dimer-
izer in POD-ATTAC mice revealed an altered expression 
pattern of nephron segment-specific sodium transporters. 
The protein abundance of NHE3, a sodium transporter that 
is mostly expressed along the proximal tubule, was strongly 
increased in POD-ATTAC mice (percentage of controls ± 
SEM: 335 ± 65.6) (Figure 2A,B). In the distal convoluted 
tubule (DCT), the total NCC protein abundance remained 
unchanged while phosphorylated NCC levels increased 
by in nephrotic mice as compared to control mice (per-
centage of controls ± SEM: 431.2 ± 73.5) (Figure 2A,B). 
Immunofluorescence staining showed the apical localiza-
tion of phosphorylated NCC in both control FVB and POD-
ATTAC nephrotic mice (Figure 2D). The abundance of 
NKCC2 protein expressed along the thick ascending limb 
of Henle (TAL) was not significantly increased and that 
of β-ENaC and full-length γ-ENaC proteins expressed along 
the connecting tubule (CNT) and collecting duct (CD) was 
unchanged. However, α-ENaC protein abundance was sig-
nificantly decreased and the abundance of the cleaved form of 
γ-ENaC protein started to rise in POD-ATTAC mice. Figure 
F I G U R E  1  Nephrotic syndrome in POD-ATTAC mice. A, Proteinuria mainly composed of albumin was detected by Coomassie 
blue staining after SDS-PAGE in urine from POD-ATTAC (POD) mice, which was absent in control (FVB) mice. Increasing concentrations of 
BSA were loaded as a control of protein size. B, Time-course of proteinuria, expressed as the ratio proteinuria (in g/L) over creatininuria (in g/L), 
C, plasma protein concentration (g/L), D, weight of ascites (g), E, urinary sodium excretion expressed as the ratio of urinary sodium (in mmol/L) 
over creatininuria (in mmol/lL), and F, glomerular filtration rate in POD and FVB mice after intraperitoneal administration of dimerizer. Values 
are means ± SEM from 1 to 14 mice in each group. Statistical differences between control mice and POD-ATTAC mice were assessed using an 
unpaired Student t test; *P < .05, **P < .01, ***P < .001
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T A B L E  3  Plasma parameters in FVB and POD-ATTAC mice 2, 3, and 5 days after NS induction
 
FVB POD
D2 D3 D5 D2 D3 D5
Na+ (mM) 154.5 ± 1.32 (4) 156.75 ± 1.13 (6) 156.33 ± 2.09 (6) 148.25 ± 2.87 (4) 149.75 ± 2.17 (4)* 156 ± 0.93 (6)
K+ (mM) 4.3 ± 0.25 (4) 3.9 ± 0.10 (6) 3.9 ± 0.25 (6) 4.95 ± 0.3 (4) 6.05 ± 0.78 (4)** 5.45 ± 0.31 (6)**
pH 7.09 ± 0.04 (4) 7.15 ± 0.02 (6) 7.13 ± 0.01 (6) 7.15 ± 0.01 (4) 7.16 ± 0.01(4) 7.15 ± 0.02 (6)
HCO
−
3
 (mM) 26.53 ± 1.46 (4) 27.97 ± 0.31 (6) 29.13 ± 0.53 (6) 27.28 ± 0.34 (4) 25.52 ± 1.12(4)* 27.58 ± 0.77 (6)
Hct (%) 35.5 ± 0.87 (4) 34.5 ± 0.54 (6) 38.5 ± 0.67 (6) 39.75 ± 1.38* (4) 37.5 ± 0.5 (4)* 36.66 ± 1.38 (6)
Hgb (g/dL) 12.03 ± 0.28 (4) 11.72 ± 0.19 (6) 13.08 ± 0.25 (6) 13.58 ± 0.5* (4) 12.82 ± 0.14 (4)* 12.46 ± 0.49 (6)
Note: Results are means ± SEM from 4-6 animals. Statistical differences between FVB and POD-ATTAC mice at each day and for each biological parameter were 
assessed using an unpaired Student t test.
*P < .05;  **P < .01. 
F I G U R E  2  Early activation of NCC in nephrotic syndrome. Two days after intraperitoneal injection of dimerizer, kidneys from nephrotic 
POD-ATTAC (POD), and control (FVB) mice were harvested. Total proteins and RNA were extracted from kidney cortices and proteins were 
separated by SDS-PAGE. Kidney slices were fixed by immersion and processed for immunohistochemistry. A, Representative Western blot 
experiment showing the abundance of total and post-translationally modified kidney tubule sodium transporters, namely: NHE3, NKCC2, total 
and phosphorylated (TP53) NCC, α and β-ENaC, and full-length and cleaved γ-ENaC. β-actin was used as a loading control. B, Bar graph shows 
the densitometric quantification of Western blots. C, qRT-PCR analysis of variations in the mRNA levels of the main tubular sodium transporters. 
D, Immunofluorescence imaging of phosphorylated (TP58) NCC shows increased staining in the distal convoluted tubules (DCT) of nephrotic 
POD mice. Values are means ± SEM from 4 mice in each group. POD-ATTAC were compared to control mice using an unpaired Student t test; 
*P < .05, **P < .01, ***P < .001
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2C shows that in contrast to protein levels, the mRNA levels 
of all the sodium transporters studied remained unchanged 
in nephrotic mice as compared with control mice indicating 
that increased NHE3 protein levels are most likely due to 
decreased protein degradation.
3.3 | Decreased NCC phosphorylation and 
increased γ-ENaC cleavage correlates with 
massive sodium retention
At day 3 after the injection of dimerizer in POD-ATTAC mice, 
a different expression pattern of nephron segment-specific 
sodium transporters was observed. Experiments revealed a 
massive increase in the cleaved form of γ-ENaC (percentage 
of controls ± SEM: 403 ± 101.1) associated with a decrease 
in full-length γ-ENaC abundance (percentage of controls ± 
SEM: 34 ± 7.7) (Figure 3A,B) and increased apical staining 
of γ-ENaC in the CNT and CD (Figure 3D) in POD-ATTAC 
mice. In contrast, the abundance of NCC protein and its phos-
phorylated form was dramatically decreased during this phase 
(percentage of controls ± SEM: 52.4 ± 8.1 and 36.6 ± 3 .9 
for NCC and phosphorylated NCC respectively) while NHE3 
protein abundance returned to baseline levels in nephrotic 
mice (Figure 3A,B). The mRNA levels of NKCC2, NCC, β-, 
and γ-ENaC were significantly decreased (Figure 3C) sug-
gesting a negative feedback on sodium transporters and chan-
nels gene transcription or mRNA degradation.
F I G U R E  3  Massive cleavage of γ-ENaC during the sodium retention phase in nephrotic syndrome. Three days after intraperitoneal injection 
of dimerizer, kidneys from nephrotic POD-ATTAC (POD) and control (FVB) mice were harvested. Total proteins and mRNA were extracted from 
kidney cortices and proteins were separated by SDS-PAGE. Kidneys slices were fixed by immersion and processed for immunohistochemistry. 
A, Representative Western blot experiment showing the abundance of total and post-translationally modified kidney tubule sodium transporters, 
namely: NHE3, NKCC2, total and phosphorylated (TP53) NCC, α and β-ENaC, and full-length and cleaved γ-ENaC. β-actin was used as a loading 
control. B, Bar graph shows the densitometric quantification of Western blots. C, qRT-PCR analysis of variations in the mRNA levels of the main 
tubular sodium transporters. D, Immunofluorescence imaging of γ-ENaC shows apical localization in principal cells in collecting ducts (CD) of 
nephrotic POD mice. Values are means ± SEM from 5 mice in each group. POD-ATTAC mice were compared to control mice using a Mann-
Whitney test; *P < .05, **P < .01, ***P < .001
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3.4 | Persisting γ-ENaC cleavage at 
steady state
Western blot analysis and immunohistochemistry experi-
ments performed at day 5 after dimerizer injection revealed 
a persistent increase in cleaved γ-ENaC abundance (percent-
age of controls ± SEM: 214.9 ± 25.1) (Figure 4A,B) associ-
ated with increased apical localization in the principal cells 
of CNT and CD (Figure 4D) in POD-ATTAC mice. This was 
associated with decreased protein abundance of α-, β-ENaC 
subunits and full-length γ-ENaC as well as NHE3 and NCC 
in nephrotic mice (Figure 4A,B). A persistent decrease in 
NKCC2, NCC, and β- and γ-ENaC mRNA levels was ob-
served (Figure 4C).
3.5 | Increased aquaporin 2 abundance 
during the early phase of NS
Aquaporin 2 (AQP2) accounts for the rate-limiting step 
of regulated water reabsorption along the CNT and CD. In 
POD-ATTAC mice, AQP2 protein levels were increased at 
days 2 (percentage of controls ± SEM: 168 ± 15) and 3 (per-
centage of controls ± SEM: 177.3 ± 19.7) and returned to 
F I G U R E  4  Decreased sodium transporters and channels at steady state. Five days after intraperitoneal injection of dimerizer, kidneys from 
nephrotic POD-ATTAC (POD) and control (FVB) mice were harvested. Total proteins and mRNA were extracted from kidney cortex and proteins 
were separated by SDS-PAGE. Kidney slices were fixed by immersion and processed for immunohistochemistry. A, Representative Western blot 
experiment showing the abundance of total and post-translationally modified kidney tubule sodium transporters, namely: NHE3, NKCC2, total 
and phosphorylated (TP53) NCC, α and β-ENaC, full-length, and cleaved γ-ENaC. β-actin was used as a loading control. B, Bar graph shows the 
densitometric quantification of Western blots. C, qRT-PCR analysis of variations in the mRNA levels of the main tubular sodium transporters. 
D, Immunofluorescence imaging of γ-ENaC shows persistent increased apical localization in principal cells in collecting ducts (CD) of nephrotic 
POD mice. Values are means ± SEM from 5 mice in each group. POD-ATTAC mice were compared to control mice using a Mann-Whitney test; 
*P < .05, **P < .01, ***P < .001
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control levels at day 5 after dimerizer injection (Figure 5A,B). 
Immunofluorescence staining performed at day 3 showed an 
increased staining and apical localization of AQP2 in the CD 
(Figure 5D). In addition, after the induction of NS, the mRNA 
levels of AQP2 were increased at days 2, 3, and 5 whereas 
hypothalamic vasopressin mRNA levels were unchanged 
(Figure 5C).
3.6 | Mathematical simulations predict a 
shift in sodium transport from PCT to ASDN
The observed changes in sodium transporter abun-
dance at each stage and in GFR were incorporated into 
a mathematical model of transport along the nephron. 
Sodium transport (Figure 6A) and oxygen consumption 
(Figure 6B) were predicted to increasingly shift toward 
the CNT and CCD. The model predicted that sodium 
transport and oxygen consumption decreased both overall 
and in the PCT at day 2 in nephrotic compared to con-
trol mice, despite the upregulation of sodium transport-
ers. This decrease results from the early impairment of the 
GFR. The predicted decrease in sodium reabsorption and 
oxygen consumption in the PCT was further pronounced 
at days 3 and 5 after induction of NS, whereas sodium 
transport, oxygen consumption and sodium transport ef-
ficiency (Figure 6C) were predicted to increase in both 
the CNT and CD.
F I G U R E  5  Aquaporin protein and mRNA levels increase after the induction of nephrotic syndrome in POD-ATTAC mice. At days 2, 3, 
and 5 after intraperitoneal injection of dimerizer, kidneys, and hypothalamus from nephrotic POD-ATTAC (POD) and control (FVB) mice were 
harvested. Total proteins and mRNA from the kidneys and total mRNA from the hypothalamus were extracted and proteins were separated by 
SDS-PAGE. Kidneys slices were fixed by immersion and processed for immunohistochemistry. A, Representative Western blot experiments 
showing aquaporin 2 (AQP2) at days 2, 3, and 5. E-cadherin was used as a loading control. B, Bar graph shows the densitometric quantification 
of Western blots. C, qRT-PCR analysis of variations in the mRNA levels of AQP2 in kidney and hypothalamic preprovasopressin at day 2, 3, and 
5. D, Immunofluorescence imaging of AQP2 shows increased staining and apical localization in collecting ducts (CD) of nephrotic POD mice at 
day 3. Values are means ± SEM from 4 mice in each group. POD-ATTAC mice were compared to control mice using an unpaired Student t test; 
*P < .05, **P < .01, ***P < .001
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3.7 | Functional diuretic tests 
confirmed the shift from NCC- to ENaC-
dependent sodium retention
We next assessed the function of segment specific sodium 
transporters by measuring diuretic-induced natriuresis 
at each day after the induction of glomerular injury. At 
day 2, the natriuretic response to hydrochlorothiazide, an 
inhibitor of NCC, and benzamil, an inhibitor of ENaC, 
were almost equivalent. As expected from Western blot-
ting and immunofluorescence experiments (see Figures 
2-4), the efficiency of benzamil compared to that of hydro-
chlorothiazide was increased at days 3 and 5 (Figure 7A). 
The ratio of the thiazide-over-benzamil- induced natriu-
resis (0.8 at day 2, 0.1 at day 3, and 0.3 at day 5) fur-
ther illustrates this time-dependent shift from NCC- to 
ENaC-mediated sodium reabsorption in POD-ATTAC 
mice (Figure 7B).
3.8 | Sodium retention is independent  
of a rise in plasma aldosterone levels in 
nephrotic syndrome
Increased plasma aldosterone (mean ± SEM: 1983 ± 
333.1 in POD-ATTAC vs 137 ± 33.4 pg/mL in FVB mice, 
P = .0009) and SGK1 mRNA levels (fold controls: 3.2) were 
increased at day 3 after dimerizer injection (Figure 8A,B) 
but were similar to control levels at days 2 and 5. This 
finding suggests that sodium retention observed in POD-
ATTAC nephrotic mice at days 2 and 5 was independent of 
increased plasma aldosterone levels. To further assess the 
F I G U R E  6  Mathematical modeling of sodium transport along the nephron shows the shift in sodium transport from proximal tubules 
to ASDN. Using an in silico model of sodium transport along the nephron, we computed the rate of sodium transport (TNa; A), the rate of O2 
consumption (QO2; B) and the efficiency of sodium transport (TNa/QO2; C) along the nephron of control mice (FVB) and nephrotic POD-ATTAC 
mice at days 2, (POD D2), 3 (POD D3), and 5 (POD D5) after dimerizer injection. Results account for observed fractional changes in transporter 
and channel abundance as shown in Figures 2-4. Shown is the predicted TNa (A), QO2 (B) and TNa/QO2 (C) for the whole nephron, PCT, PST, 
cTAL, mTAL, DCT, CNT, CCD, outer medullary (OMCD), and inner medullary (IMCD) collecting duct. Relative to control mice, sodium 
reabsorption, oxygen consumption, and sodium transport efficiency are predicted to be shifted to the CNT at days 3 and 5 after dimerizer injection 
in NS mice.
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role of aldosterone in sodium retention in POD-ATTAC 
mice, control, and nephrotic mice received 50 mg/kg 
potassium-canrenoate (sc), a competitive antagonist of 
the MR. Results show that potassium-canrenoate neither 
prevented ascites (Figure 8C,D) nor reduced the extent of 
γ-ENaC cleavage in nephrotic POD-ATTAC mice (Figure 
8E,F). These findings support the idea that γ-ENaC cleav-
age and sodium retention are at least partly independent 
of the transient rise (day 3) in plasma aldosterone levels 
found in POD-ATTAC mice.
3.9 | Low potassium diet prevented 
hyperkalemia, NCC dephosphorylation and 
γ-ENaC cleavage at day 3
POD-ATTAC mice were fed a low potassium diet start-
ing from the day of NS induction to prevent hyperkaliemia. 
Analyses performed at day 3 showed that low potassium-fed 
nephrotic mice displayed unchanged plasma potassium lev-
els compared to control FVB mice (Figure 9B). Western blot 
analysis at day 3 revealed increased NCC protein abundance 
and phosphorylation levels associated with decreased abun-
dance of cleaved γ-ENaC compared to normal potassium-fed 
nephrotic mice. As expected, SPAK protein abundance and 
phosphorylation levels were increased in low potassium fed 
control FVB mice but were surprisingly decreased in ne-
phrotic mice fed either a low or normal potassium diet (Figure 
9B,C). These observations suggest that hyperkaliemia is 
responsible for the shift from NCC- to ENaC-dependent so-
dium retention and this occurs independently of SPAK.
4 |  DISCUSSION
In this study, we showed that sodium retention occurs in differ-
ent nephron segments depending on the stage of development 
of NS, and that potassium intake has an important role in de-
termining the major tubular site of sodium reabsorption in NS.
4.1 | Limitations and advantages of the 
POD-ATTAC mouse model
We used the POD-ATTAC mouse model10 to study the early 
development and time-course of sodium retention along the 
nephron. With respect to previous mouse models, POD-
ATTAC mice do not display the non-specific tubular and/
or vascular alterations that can be associated with drug- 
induced glomerular injuries.6 These transgenic mice express 
a FKBP/caspase-8 fusion protein under the control of the 
podocin promoter.10 Activation of endogenous caspase-8 by 
a chemical dimerizer leads to specific and inducible podo-
cyte apoptosis, massive proteinuria, hypoproteinemia, and 
ascites. The podocyte specific and dose-dependent apopto-
sis in POD-ATTAC mice closely mimics human glomerular 
diseases initiated by podocyte injury such as minimal change 
disease and focal segmental glomerulosclerosis.10 Unlike the 
F I G U R E  7  Diuretic tests confirm the time-dependent shift from NCC to ENaC activity. Two, three, and five days after intraperitoneal 
injection of dimerizer, mice were given a single dose of hydrocholorothiazide (Thiazide in the graph) through intraperitoneal injection, which 
inhibits NCC in the distal convoluted tubule, or benzamil, which inhibits ENaC in the connecting tubule and the collecting duct. Results are 
expressed as the ratio of diuretic-induced to baseline natriuresis in A and the ratio of hydrochlorothiazide over benzamil-induced natriuresis in B. 
Values are means ± SEM from 4 mice in each group. Hydrochlorothiazide-induced natriuresis was compared to benzamil-induced natriuresis at 
each day with an unpaired Student t test in A; *P < .05, **P < .01, ***P < .001
??
??
??
??
???????? ???????????? ??
??????????????
??????????????? ????????????????
???
???????
?????????
?????????
???
????? ????? ??????????
????????????????
??????????
(A) (B)
12 |   DIZIN et al.
constitutive knock-out mice models for podocyte-specific 
proteins like podocin9 or nephrin,8 the POD-ATTAC mice 
display low early mortality, allowing us to study NS from 
the onset to the steady-state. Moreover, the nephrotic pheno-
type of POD-ATTAC mice was reproducible between het-
erozygotes, whereas the inducible inactivation of podocin in 
mature kidneys led to phenotypic variability concerning the 
progression of renal disease.9 However, the POD-ATTAC 
mice model possesses several limitations: one of them is 
the early impairment of renal function after the induction of 
NS that may partly stem from a prerenal dysfunction due to 
volume contraction and/or an organic renal dysfunction due 
to the loss of podocytes. The second limitation is the rapid 
onset of massive proteinuria within 3 d which is similar to 
the PAN-induced nephrotic model,3,4 but more rapid than ac-
quired human diseases.
4.2 | Activation of sodium transporters 
in PCT and DCT during the early phase of 
nephrotic syndrome
Based on biological parameters we identified three phases 
in the development of NS in POD-ATTAC mice: the onset 
F I G U R E  8  Sodium retention is partially independent of aldosterone in nephrotic syndrome. A, Plasma aldosterone levels in controls (FVB) 
and POD-ATTAC (POD) mice, at days 2, 3, and 5 after dimerizer injection. B, qRT-PCR analysis of variations in the mRNA levels of SGK1 
in FVB and POD mice at days 2, 3, and 5 after dimerizer injection. Potassium-canrenoate (CAN) was administered subcutaneously for 5 days 
starting one day before intraperitoneal injection of the dimerizer. FVB and control POD mice were administered the same volume of 5% glucose 
subcutaneously. Three days after intraperitoneal injection of the dimerizer, kidneys from control FVB mice and nephrotic POD, treated or untreated 
with potassium-canrenoate, were harvested. Total proteins were extracted and separated by SDS-PAGE. C, Weight of FVB, POD, and POD+CAN 
mice. D, Quantification of ascites at day 3 in FVB, POD, and POD+CAN mice. E, Western blotting experiments showing full length and cleaved 
γ-ENaC of FVB, POD, and POD+CAN mice. E-cadherin was used as a loading control. F, Bar graph shows the densitometric quantification of 
Western blots. Values are means ± SEM from 4 mice in each group. POD-ATTAC mice were compared to control mice using unpaired Student’s 
t test in A and B. POD-ATTAC mice treated with canrenone, without canrenone and control mice were compared using a Kruskal-Wallis test in D 
and F; *P < .05, **P < .01, ***P < .001
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of proteinuria occurring at day 2, massive proteinuria and 
sodium retention occurring at day 3, and the initiation of 
a steady-state at day 5. At day 2, when nephrotic POD-
ATTAC mice displayed hypovolemia associated with 
proteinuria, we found increased NHE3 protein levels and 
phosphorylated NCC. These sodium transporters are regu-
lated by the SRAA, which is activated under hypovolemia. 
NHE3 is up-regulated by the physiological concentration 
of angiotensin II.15 A recent work showed that filtered 
angiotensinogen is reabsorbed by megalin in the PCT in 
another model of podocyte injury and non-selective pro-
teinuria.16,17 Angiotensinogen is then converted into angio-
tensin II and locally increases NHE3 protein abundance, 
enhancing sodium reabsorption in the PCT.16 NCC is also 
regulated by angiotensin II and aldosterone.18 In our study, 
plasma aldosterone abundance were unchanged at day 2 
but may exert permissive effects. Moreover, angiotensin II 
was shown to activate NCC in a WNK (with-no-lysine ki-
nases) 4-dependent manner.19 The mRNA levels of sodium 
channels and transporters were unchanged at day 2. This 
F I G U R E  9  Low potassium diet prevented hyperkalemia and the shift in sodium transport from the distal convoluted tubule to the collecting 
system. A, Urinary potassium excretion. B, Kalemia at day 3 after NS induction in FVB and POD-ATTAC mice fed a normal (NK) or low (LK) 
potassium diet. C, Representative western blot experiments showing the increased abundance of total and phosphorylated NCC (TP58) and 
decreased abundance of cleaved γ-ENaC in nephrotic mice fed a LK diet compared to nephrotic mice fed a NK diet. Total and phosphorylated 
SPAK (pSer373) abundance were increased in FVB mice fed with LK but not in nephrotic mice fed with either NK or LK. D, Bar graph shows 
densitometric quantification of Western blots, normalized with Coomassie staining. Values are means ± SEM from 3-8 mice in each group. The four 
groups: FVB NK, FVB LK, POD-ATTAC NK, and POD-ATTAC LK were compared with one-way ANOVA. *P < .05, **P < .01, ***P < .001
(C)
(A)
???
??
??? ????????????? ??
?????? ????
????? ??
??? ????? ?? ????
??????????????????
????????????????
???
?????
???????
???????
?????
? ? ? ? ? ?????? ?????
??? ?? ??? ??????
(B)
(D)
?????????
????????????
?????? ??? ??????? ???????????
?????????? ?????????????? ??????? ????
???? ?????????
?????????
????????????
??????? ??? ???????? ???????????
?????????? ??????????? ???????? ?????
??? ???? ????????
???????
??????
???????? ??? ???????????????? ??????????
??????????? ?????????????? ????? ?????? ? ???????
???
14 |   DIZIN et al.
uncoupling between mRNA and protein levels may indicate 
that observed increases in NHE3 and NKCC2 (although 
non-significant) protein abundance may rely on increased 
mRNA translation or decreased protein degradation. The 
latter is more likely since regulation of protein abundance 
via modulation of protein degradation rate has been demon-
strated for several sodium transporters such as the sodium/
phosphate cotransporter NaPi-220 and the Na,K-ATPase.21
4.3 | Hyperkalemia induces the shift from 
upstream segments to the ASDN
Three days after the induction of podocyte loss, GFR decreased 
by 50% and hyperkalemia associated with low kaliuresis, indi-
cating a renal origin, was observed. Results suggest a shift in 
sodium retention from the PCT and DCT at day 2 to the CNT 
and CD at day 3, as indicated by the normalized abundance 
of NHE3, decreased abundance of NCC and phosphorylated 
NCC, and increased abundance of cleaved γ-ENaC. This shift 
was prevented by a low potassium diet supporting the hypoth-
esis that potassium homeostasis is a major determinant of the 
tubular site of sodium reabsorption in NS.
Hyperkalemia may promote the decrease in phosphorylated 
NCC at day 3 in order to increase sodium and fluid delivery to 
the potassium-secreting segment of the kidney tubule, ie, the 
DCT2, CNT, and CD. The increased sodium concentration in 
the fluid delivered to the distal nephron stimulates the entry of 
sodium through ENaC, thereby augmenting the lumen-nega-
tive transepithelial potential that drives the secretion of potas-
sium through ROMK/BK channels. The aldosterone paradox 
states that the regulation of renal handling of potassium pre-
vails over that of sodium along the kidney tubule. Thus, NCC 
is inhibited under a large potassium load even when associ-
ated with sodium depletion, in order to increase potassium 
secretion by the distal parts of the nephron. This mechanism 
is directly mediated by local WNK activity, resulting in the de-
coupling of NCC and ENaC in ASDN as a first defense against 
potassium variations.22 WNK 1, 3, and 4 are expressed in the 
kidney and are inhibited by high intracellular chloride result-
ing from high extracellular potassium. The binding of chloride 
prevents the activation of WNK by autophosphorylation, lead-
ing to a SPAK-dependent inhibition of NCC.23 In FVB control 
mice fed a low potassium diet, we observed the expected ac-
tivation of SPAK and NCC. Since plasma potassium did not 
detectably decrease and underwent little variation, this SPAK 
activation is likely due to “feed-forward” control of potassium 
homeostasis (Figure 10). Indeed, “feed-forward” system aims 
to prevent rises of potassium levels after an oral load, inde-
pendently of plasma potassium and aldosterone,24 as opposed 
to the “feedback” control. Nephrotic POD-ATTAC mice fed a 
normal potassium diet showed high plasma potassium levels 
F I G U R E  1 0  Illustrative summary. Images are from Servier Smart Medical Art.
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and decreased NCC/SPAK abundance and phosphorylation, as 
expected. In this case, the “feedback” control of potassium ho-
meostasis may have prevailed since potassium intake was nor-
mal (Figure 10).24 Surprisingly, despite increased protein levels 
of NCC and phosphorylated NCC, SPAK, and phosphorylated 
SPAK levels were decreased in nephrotic POD-ATTAC mice 
fed a low potassium diet. Since urinary potassium excretion 
was decreased in these mice, plasma potassium did not change 
compared with control FVB mice. Since extracellular potas-
sium does not change, one can speculate that intracellular chlo-
ride and WNK/SPAK activities did not change as well. These 
results raise the hypothesis of a SPAK-independent activation 
of NCC.
4.4 | γ-ENaC cleavage correlates with 
massive sodium retention in NS
According to literature, ENaC plays a key role in sodium 
retention in NS. Our results show that α- and β-subunits 
were either unchanged or decreased in POD-ATTAC mice, 
but that cleaved γ-subunit abundance was increased when 
sodium retention was massive. We have shown previ-
ously that overexpressing γ-ENaC in cultured CD principal 
cells increased ENaC apical expression and activity.21,25 
We confirmed the importance of the γ-subunit in ENaC 
activity in our model with diuretic tests that showed the 
increase in benzamil-induced compared to hydrochloro-
thiazide-induced natriuresis accompanying the increase 
in cleaved γ-ENaC. Regulation of γ-ENaC involves its 
cleavage by proteases in order to increase its open prob-
ability and its cell surface expression.26 Increased cleavage 
of ENaC subunits associated with decreased mRNA and 
uncleaved protein levels in POD-ATTAC mice at days 3 
and 5 after induction of NS implies a stimulation of the 
proteolytic maturation of pre-existing ENaC subunits. 
γ-ENaC may be cleaved by intracellular furin, extracel-
lular membrane-bound proteases like CAP1/prostasin, and 
soluble proteases. We detected a 75 kDa fragment possi-
bly accompanied by a 70 kDa fragment of γ-ENaC with an 
antibody reacting with the C-terminal part, which is com-
patible with furin27 and CAP1/prostasin28 cleavage. It has 
been shown that soluble extracellular proteases present in 
nephrotic urine may also cleave γ-ENaC in mice and hu-
mans.3 At day 3, nephrotic mice still displayed biological 
parameters indicative of relative hypovolemia such as in-
creased hematocrit and hemoglobin. Sodium restriction is a 
strong activator of γ-ENaC cleavage in rats.29 This process 
is dependent on aldosterone as evinced by the finding that 
rats subjected to aldosterone infusion displayed increased 
cleaved γ-ENaC within 3 hours after the beginning of infu-
sion. The results suggest that aldosterone induces the rapid 
cleavage and apical addressing of ENaC.30 Moreover, the 
cleaved γ-subunit is absent in kidney tubule-specific MR 
knockout mice.31 However, the mechanism of γ-ENaC 
cleavage in NS is still debated.
4.5 | Aldosterone-independent regulation of 
sodium retention
According to the underfilling theory, aldosterone plays a 
central role in sodium retention because relative hypov-
olemia is frequently associated with NS, stimulating RAAS 
and thus aldosterone secretion. However, sodium retention 
persisted in aldosterone-clamped PAN rats,5 and sodium re-
tention took place only in the nephrotic kidney in the case 
of unilateral PAN injection.32 Furthermore, nephrotic mice 
displayed high plasma aldosterone and increased mRNA 
levels of the aldosterone target gene SGK1 at day 3 but 
normal levels of both were observed when urinary sodium 
was reduced at day 2. We have also shown that canrenone 
administration to nephrotic mice did not prevent ascites, 
weight gain, nor γ-ENaC cleavage at day 3, as previously 
shown in mice subjected to doxorubicin-induced NS.33 
Those results suggest at least a partial independence of so-
dium retention from increased plasma aldosterone levels 
and mineralocorticoid receptor activation. However, al-
dosterone may participate in the decoupling of NCC and 
ENaC at day 3 via SGK1, which phosphorylates WNK4 in 
the DCT thus preventing WNK4-dependent ENaC endocy-
tosis.34 These results reveal a complex local regulation and 
interplay between transporters and channels in NS where 
aldosterone may exert a permissive effect.
4.6 | Mechanism of water retention
Apical cell surface expression of AQP2 is rate-limiting for 
water permeability of the CD.35 At days 2 and 3, increased 
AQP-2 mRNA and protein levels together with hypona-
tremia indicate water retention accompanying sodium re-
tention during the hypovolemic period of NS. Vasopressin 
is the major controller of AQP2 expression and apical tar-
geting.36 Surprisingly, at any stage of NS, hypothalamic 
vasopressin mRNA levels were not increased in nephrotic 
mice compared to control mice in our study. On one hand, 
we cannot exclude an early and transient increase in vaso-
pressin mRNA levels. However, vasopressin has a short 
half-life that makes long lasting effects unlikely. On the 
other hand, AQP2 protein expression is regulated by other 
factors which are relevant in our study, such as aldoster-
one,37 and interstitial tonicity38 generated by avid sodium 
chloride reabsorption. Therefore, the observed increase in 
AQP2 expression is likely independent of increased vaso-
pressin secretion.
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Normalization of plasma sodium concentration and AQP2 
protein levels at day 5 contrasted with the persisting increase of 
AQP2 mRNA levels. Uncoupling between AQP2 protein and 
mRNA levels in the cortex has been described in certain con-
ditions in rats for instance such as fasting.39 Nephrotic and con-
trol mice displayed similar amounts of water and food intake 
compared to FVB mice (Supplementary Figure 1), suggesting 
that another mechanism of uncoupling is at work. Moreover, 
this observation indicates that the central control of thirst or 
sodium appetite40 of hypovolemic nephrotic mice was not a 
major contributor in the altered sodium and water balance in 
our study. Our results rather suggest that intrarenal mechanisms 
are at work to drive massive sodium and water retention.
5 |  CONCLUSIONS
The POD-ATTAC mouse model, despite its limitations, re-
veals that sodium retention in NS is a continuous process and 
can occur in different segments of the nephron, depending on 
hemodynamics, GFR, and plasma potassium. In this model, 
the underfilling mechanism dominates and potassium bal-
ance requirements determine the site of sodium reabsorption 
in NS. Aldosterone may play a permissive role in the shift 
from the DCT to ASDN and in the activation of ENaC under 
conditions of hyperkalemia.
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